Novo Nordisk shares plunge amid lower 2026 sales outlook
Go back to Novo Nordisk shares plunge amid lower 2026 sales outlook| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1098.57 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1098.57 | 52 Week High | $88.16 | |||
| Open | $1098.57 | 52 Week Low | $67.88 | |||
| Day High | $1098.57 | P/E | 254.30 | |||
| Day Low | $1098.57 | EPS | $4.32 | |||
| Volume | 10,293 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 43.19 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.19 | 52 Week High | $59.00 | |||
| Open | $43.19 | 52 Week Low | $32.80 | |||
| Day High | $43.19 | P/E | N/A | |||
| Day Low | $43.19 | EPS | $0.00 | |||
| Volume | 385,658 | |||||
